Andrea Wagner, PhD

Chief Executive Officer & Cofounder

Dr. Andrea Wagner is a seasoned pharmaceutical executive with 20+ years of experience scaling CDMOs. She cofounded and led two successful CDMOs including one acquired by AMRI (now Curia) in 2010 and Berkshire Sterile Manufacturing (now Sharp Sterile) which sold to Sharp Services in 2023.

As CEO and cofounder of PharmaPhixx, Andrea brings a strong understanding of the pain points facing pharmaceutical manufacturers, particularly in fill-finish and aseptic operations. Her leadership is shaped by a blend of scientific expertise and commercial insight.

She holds a PhD in Environmental Health and Toxicology, a Master’s in Analytical Chemistry, and a Bachelor’s in Chemistry, and has held senior business development roles at Catalent, AMRI, and various life sciences startups.